Establish HRD cell lines to generate "the HRD gene signature". (a) Schematic diagram of HR repair assay. The DRGFP reporter substrate was integrated into cellular genomic DNA. SceGFP contains an I-SceI endonuclease site within the coding region, which abolishes GFP expression. iGFP is a truncated GFP, which contains homologous sequence for the SceGFP. Expression of I-SceI induces a single DSB in the genome. When this DSB is repaired by HR, the expression of GFP can be restored and analyzed by flow cytometry to indicate the efficiency of HR repair. (b) MCF-10A cells were infected with lentiviral particles targeting BRCA1, RAD51 or BRIT1. Selected stable clones were subject to HR repair assay as described above. Each value is relative to the percentage of GFP-positive (GFP+) cells in I-SceI-transfected control cells. Results are show as mean + SD from three independent experiments; Student's t-test was used to test statistical significance. (c) Whole cell lysate was analyzed by western blotting via indicated antibodies, demonstrating effective knockdown by shRNA (target sequences in Supplementary Table 3 ). Flow cytometry analyses of cell cycle distribution in these cell lines were shown next to Western blots. 
Supplementary Figure 7:
The HRD Gene Signature Predicts HR-deficiency and Sensitivity to PARP Inhibitors in Cancer Cells. (a) Cells were seeded in a very low density and treated with indicated concentrations of PARP inhibitor olaparib for 10-15 days to allow colony formation. The rate of cell survival was determined by colony-formation assay. Colonies were stained with 0.25% crystal violet/25% methanol and counted both manually and digitally using ImageJ software. Each value was relative to control cells that contain only DMSO (solvent for olaparib) and represents the mean ± SEM from three independent experiments. Student's t-test showed that the drug response to olaparib differed between control cell lines and individual knockdown cell lines (P<0.05). 
